Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

Requirement for the collagen receptor Endo180 in collagen gel contraction mediated by corneal fibroblasts.

Nishida K, Sugioka K, Murakami J, Kodama-Takahashi A, Nanri I, Mishima H, Nishida T, Kusaka S.

Exp Eye Res. 2020 Feb;191:107933. doi: 10.1016/j.exer.2020.107933. Epub 2020 Jan 11.

PMID:
31935380
2.

Multiple animal positioning system shows that socially-reared mice influence the social proximity of isolation-reared cagemates.

Endo N, Ujita W, Fujiwara M, Miyauchi H, Mishima H, Makino Y, Hashimoto L, Oyama H, Makinodan M, Nishi M, Tohyama C, Kakeyama M.

Commun Biol. 2018 Dec 11;1(1):225. doi: 10.1038/s42003-018-0213-5.

PMID:
31924861
3.

KAT6B-related disorder in a patient with a novel frameshift variant (c.3925dup).

Hamaguchi Y, Aoki M, Watanabe S, Mishima H, Yoshiura KI, Moriuchi H, Dateki S.

Hum Genome Var. 2019 Dec 13;6:54. doi: 10.1038/s41439-019-0085-3. eCollection 2019.

4.

How Does a Walker Pass Between Two People Standing in Different Configurations? Influence of Personal Space on Aperture Passing Methods.

Tomono T, Makino R, Furuyama N, Mishima H.

Front Psychol. 2019 Dec 4;10:2651. doi: 10.3389/fpsyg.2019.02651. eCollection 2019.

5.

Dietary instructions focusing on meal-sequence and nutritional balance for prediabetes subjects: An exploratory, cluster-randomized, prospective, open-label, clinical trial.

Yabe D, Kuwata H, Fujiwara Y, Sakaguchi M, Moyama S, Makabe N, Murotani K, Asano H, Ito S, Mishima H, Takase H, Ota N, Seino Y, Hamamoto Y, Kurose T, Seino Y.

J Diabetes Complications. 2019 Dec;33(12):107450. doi: 10.1016/j.jdiacomp.2019.107450. Epub 2019 Oct 19.

6.

Stimulation of Phagocytic Activity in Cultured Human Corneal Fibroblasts by Plasminogen.

Sato T, Sugioka K, Kodama-Takahashi A, Murakami J, Saito A, Mishima H, Nishida T, Kusaka S.

Invest Ophthalmol Vis Sci. 2019 Oct 1;60(13):4205-4214. doi: 10.1167/iovs.19-27736.

PMID:
31618424
7.

Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials.

Maeda H, Hazama S, Iwamoto S, Oba K, Tsunedomi R, Okayama N, Suehiro Y, Yamasaki T, Nakagami Y, Suzuki N, Nagano H, Sakamoto J, Mishima H, Nagata N.

Oncol Lett. 2019 Nov;18(5):4555-4562. doi: 10.3892/ol.2019.10787. Epub 2019 Aug 29.

8.

Atypical phenotype without fever in a Japanese family with an autosomal dominant transmission of familial Mediterranean fever due to heterozygous MEFV Thr577Asn mutations.

Endo Y, Koga T, Nakashima M, Mishima H, Yoshiura KI, Kawakami A.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):161-162. Epub 2019 Sep 23. No abstract available.

10.

Ten-year results of concentrated autologous bone marrow aspirate transplantation for osteonecrosis of the femoral head: a retrospective study.

Tomaru Y, Yoshioka T, Sugaya H, Kumagai H, Hyodo K, Aoto K, Wada H, Akaogi H, Yamazaki M, Mishima H.

BMC Musculoskelet Disord. 2019 Sep 5;20(1):410. doi: 10.1186/s12891-019-2797-4.

11.

Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E.

Nagayama Y, Mishima H.

Endocrine. 2019 Dec;66(3):607-613. doi: 10.1007/s12020-019-02063-z. Epub 2019 Sep 2.

PMID:
31478162
12.

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer.

Munemoto Y, Nakamura M, Takahashi M, Kotaka M, Kuroda H, Kato T, Minagawa N, Noura S, Fukunaga M, Kuramochi H, Touyama T, Takahashi T, Miwa K, Satake H, Kurosawa S, Miura T, Mishima H, Sakamoto J, Oba K, Nagata N.

Eur J Cancer. 2019 Sep;119:158-167. doi: 10.1016/j.ejca.2019.07.006. Epub 2019 Aug 21.

13.

Effects of teriparatide on bone formation in novel unidirectional porous beta-tricalcium phosphate.

Kumagai H, Funayama T, Sugaya H, Yoshioka T, Makihara T, Tomaru Y, Arai N, Sato K, Miura K, Noguchi H, Abe T, Koda M, Mishima H, Yamazaki M.

J Biomater Appl. 2019 Nov;34(5):721-727. doi: 10.1177/0885328219868811. Epub 2019 Aug 6. No abstract available.

PMID:
31387420
14.

Target Capture/Next-Generation Sequencing for Nonsyndromic Cleft Lip and Palate in the Japanese Population.

Shibano M, Watanabe A, Takano N, Mishima H, Kinoshita A, Yoshiura KI, Shibahara T.

Cleft Palate Craniofac J. 2020 Jan;57(1):80-87. doi: 10.1177/1055665619857650. Epub 2019 Jul 23.

PMID:
31337262
15.

Melatonin is a potential drug for the prevention of bone loss during space flight.

Ikegame M, Hattori A, Tabata MJ, Kitamura KI, Tabuchi Y, Furusawa Y, Maruyama Y, Yamamoto T, Sekiguchi T, Matsuoka R, Hanmoto T, Ikari T, Endo M, Omori K, Nakano M, Yashima S, Ejiri S, Taya T, Nakashima H, Shimizu N, Nakamura M, Kondo T, Hayakawa K, Takasaki I, Kaminishi A, Akatsuka R, Sasayama Y, Nishiuchi T, Nara M, Iseki H, Chowdhury VS, Wada S, Ijiri K, Takeuchi T, Suzuki T, Ando H, Matsuda K, Somei M, Mishima H, Mikuni-Takagaki Y, Funahashi H, Takahashi A, Watanabe Y, Maeda M, Uchida H, Hayashi A, Kambegawa A, Seki A, Yano S, Shimazu T, Suzuki H, Hirayama J, Suzuki N.

J Pineal Res. 2019 Oct;67(3):e12594. doi: 10.1111/jpi.12594. Epub 2019 Jul 19.

16.

[Extreme Obese Patients who Underwent Cardiac Surgery after Preoperative Weight Reduction;Report of Two Cases].

Naito J, Matsunaga H, Mishima H, Kobayashi A, Takahashi M, Matsuoka Y, Otsuji M, Ishikawa S.

Kyobu Geka. 2019 May;72(5):389-394. Japanese.

PMID:
31268039
17.

Inhibition by Epigallocatechin Gallate of IL-1-Induced Urokinase-Type Plasminogen Activator Expression and Collagen Degradation by Corneal Fibroblasts.

Sugioka K, Yoshida K, Murakami J, Itahashi M, Mishima H, Nishida T, Kusaka S.

Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):2895-2903. doi: 10.1167/iovs.19-27306.

PMID:
31266061
18.

Evaluation of Face2Gene using facial images of patients with congenital dysmorphic syndromes recruited in Japan.

Mishima H, Suzuki H, Doi M, Miyazaki M, Watanabe S, Matsumoto T, Morifuji K, Moriuchi H, Yoshiura KI, Kondoh T, Kosaki K.

J Hum Genet. 2019 Aug;64(8):789-794. doi: 10.1038/s10038-019-0619-z. Epub 2019 May 29.

PMID:
31138847
19.

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Taguchi M, Mishima H, Shiozawa Y, Hayashida C, Kinoshita A, Nannya Y, Makishima H, Horai M, Matsuo M, Sato S, Itonaga H, Kato T, Taniguchi H, Imanishi D, Imaizumi Y, Hata T, Takenaka M, Moriuchi Y, Shiraishi Y, Miyano S, Ogawa S, Yoshiura KI, Miyazaki Y.

Haematologica. 2020 Jan 31;105(2):358-365. doi: 10.3324/haematol.2019.219386. Print 2020.

20.

Hepatectomy for rapidly growing solitary liver metastasis from non-small cell lung cancer: a case report.

Hakoda H, Sekine Y, Ichimura H, Ueda K, Aoki S, Mishima H, Sako A, Kobayashi K, Sakata A, Sato Y.

Surg Case Rep. 2019 May 2;5(1):71. doi: 10.1186/s40792-019-0633-6.

21.

Clival Metastasis of Hepatocellular Carcinoma with an Initial Histopathological Diagnosis of Atypical Pituitary Adenoma.

Mishima H, Ayabe J, Watanabe M, Togin S, Tsuchiya Y, Kawasaki T, Noda N, Maruyama T, Tanaka Y.

J Neurol Surg Rep. 2019 Jan;80(1):e18-e22. doi: 10.1055/s-0039-1685207. Epub 2019 Apr 3.

22.

Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).

Nagata N, Maeda H, Ishibashi K, Hirata K, Makiyama A, Iwamoto S, Takemoto H, Imasato M, Yoshida Y, Munemoto Y, Tanaka C, Morita Y, Hotta Y, Toyofuku A, Nagasaka T, Morita S, Sakamoto J, Mishima H.

Med Oncol. 2019 Apr 24;36(6):46. doi: 10.1007/s12032-019-1254-4.

PMID:
31020480
23.

Nonsense mutation in CFAP43 causes normal-pressure hydrocephalus with ciliary abnormalities.

Morimoto Y, Yoshida S, Kinoshita A, Satoh C, Mishima H, Yamaguchi N, Matsuda K, Sakaguchi M, Tanaka T, Komohara Y, Imamura A, Ozawa H, Nakashima M, Kurotaki N, Kishino T, Yoshiura KI, Ono S.

Neurology. 2019 May 14;92(20):e2364-e2374. doi: 10.1212/WNL.0000000000007505. Epub 2019 Apr 19.

24.

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.

Tomita N, Kunieda K, Maeda A, Hamada C, Yamanaka T, Sato T, Yoshida K, Boku N, Nezu R, Yamaguchi S, Mishima H, Sadahiro S, Muro K, Ishiguro M, Sakamoto J, Saji S, Maehara Y.

Br J Cancer. 2019 Apr;120(7):689-696. doi: 10.1038/s41416-019-0410-0. Epub 2019 Mar 5.

25.

Identification of a homozygous frameshift variant in RFLNA in a patient with a typical phenotype of spondylocarpotarsal synostosis syndrome.

Shimizu H, Watanabe S, Kinoshita A, Mishima H, Nishimura G, Moriuchi H, Yoshiura KI, Dateki S.

J Hum Genet. 2019 May;64(5):467-471. doi: 10.1038/s10038-019-0581-9. Epub 2019 Feb 22.

PMID:
30796325
26.

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.

Tanioka H, Honda M, Tanaka C, Morita Y, Ishibashi K, Kato T, Matsuda C, Kataoka M, Satake H, Munemoto Y, Kobayashi K, Takahashi M, Nakata K, Sakamoto J, Oba K, Mishima H.

Int J Clin Oncol. 2019 Jul;24(7):836-841. doi: 10.1007/s10147-019-01414-0. Epub 2019 Feb 18.

PMID:
30778794
27.

Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.

Yamashita Y, Nishikawa A, Iwahashi Y, Fujimoto M, Sasaki I, Mishima H, Kinoshita A, Hemmi H, Kanazawa N, Ohshima K, Imadome KI, Murata SI, Yoshiura KI, Kaisho T, Sonoki T, Tamura S.

Int J Hematol. 2019 Jun;109(6):744-750. doi: 10.1007/s12185-019-02595-0. Epub 2019 Jan 31.

PMID:
30706328
28.

A homozygous splice site ROBO1 mutation in a patient with a novel syndrome with combined pituitary hormone deficiency.

Dateki S, Watanabe S, Mishima H, Shirakawa T, Morikawa M, Kinoshita E, Yoshiura KI, Moriuchi H.

J Hum Genet. 2019 Apr;64(4):341-346. doi: 10.1038/s10038-019-0566-8. Epub 2019 Jan 28.

PMID:
30692597
29.
30.

Patients with SATB2-associated syndrome exhibiting multiple odontomas.

Kikuiri T, Mishima H, Imura H, Suzuki S, Matsuzawa Y, Nakamura T, Fukumoto S, Yoshimura Y, Watanabe S, Kinoshita A, Yamada T, Shindoh M, Sugita Y, Maeda H, Yawaka Y, Mikoya T, Natsume N, Yoshiura KI.

Am J Med Genet A. 2018 Dec;176(12):2614-2622. doi: 10.1002/ajmg.a.40670. Epub 2018 Dec 21.

PMID:
30575289
31.

Multiple animal positioning system shows that socially-reared mice influence the social proximity of isolation-reared cagemates.

Endo N, Ujita W, Fujiwara M, Miyauchi H, Mishima H, Makino Y, Hashimoto L, Oyama H, Makinodan M, Nishi M, Tohyama C, Kakeyama M.

Commun Biol. 2018 Dec 11;1:225. doi: 10.1038/s42003-018-0213-5. eCollection 2018.

32.

Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer.

Iwamoto S, Maeda H, Hazama S, Oba K, Okayama N, Suehiro Y, Yamasaki T, Suzuki N, Nagano H, Sakamoto J, Mishima H, Nagata N.

J Cancer. 2018 Oct 18;9(22):4092-4098. doi: 10.7150/jca.26840. eCollection 2018.

33.

Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.

Hidaka H, Higashimoto K, Aoki S, Mishima H, Hayashida C, Maeda T, Koga Y, Yatsuki H, Joh K, Noshiro H, Iwakiri R, Kawaguchi A, Yoshiura KI, Fujimoto K, Soejima H.

Clin Epigenetics. 2018 Dec 4;10(1):150. doi: 10.1186/s13148-018-0578-9.

34.
35.

Identification of a variant associated with early-onset diabetes in the intron of the insulin gene with exome sequencing.

Matsuno S, Furuta H, Kosaka K, Doi A, Yorifuji T, Fukuda T, Senmaru T, Uraki S, Matsutani N, Furuta M, Mishima H, Iwakura H, Nishi M, Yoshiura K, Fukui M, Akamizu T.

J Diabetes Investig. 2019 Jul;10(4):947-950. doi: 10.1111/jdi.12974. Epub 2018 Dec 5.

36.

Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases.

Masuishi T, Taniguchi H, Eto T, Komori A, Mitani S, Hasegawa H, Narita Y, Ishihara M, Tanaka T, Kadowaki S, Ura T, Ando M, Tajika M, Nomura M, Sato Y, Mishima H, Muro K.

Anticancer Res. 2018 Nov;38(11):6501-6506. doi: 10.21873/anticanres.13014.

PMID:
30396978
37.

Plasminogen-Dependent Collagenolytic Properties of Staphylococcus aureus in Collagen Gel Cultures of Human Corneal Fibroblasts.

Sugioka K, Kodama-Takahshi A, Sato T, Okada K, Murakami J, Park AM, Mishima H, Shimomura Y, Kusaka S, Nishida T.

Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5098-5107. doi: 10.1167/iovs.18-24925.

PMID:
30372736
38.

Laparoscopic treatment of a vesicointestinal fistula due to a Meckel's diverticulum: a case report and review of the literature.

Hakoda H, Mishima H, Habu T, Murai S, Maeno R, Yokomizo Y, Inagaki Y, Maruyama T, Matsui Y, Sako A.

Clin J Gastroenterol. 2018 Dec;11(6):476-480. doi: 10.1007/s12328-018-0878-9. Epub 2018 Jun 18. Review.

PMID:
29915984
39.

The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).

Nishikawa K, Aoyama T, Oba MS, Yoshikawa T, Matsuda C, Munemoto Y, Takiguchi N, Tanabe K, Nagata N, Imano M, Oshiro M, Fukushima R, Kataoka M, Morita S, Tsuburaya A, Mishima H, Kono T, Sakamoto J.

J Cancer. 2018 Apr 19;9(10):1725-1730. doi: 10.7150/jca.24733. eCollection 2018.

40.

Mid-term results of concentrated autologous bone marrow aspirate transplantation for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.

Tomaru Y, Yoshioka T, Sugaya H, Shimizu Y, Aoto K, Wada H, Akaogi H, Yamazaki M, Mishima H.

Int Orthop. 2018 Jul;42(7):1623-1630. doi: 10.1007/s00264-018-3959-y. Epub 2018 Apr 28.

PMID:
29705871
41.

Comparative Analysis of Cellular and Growth Factor Composition in Bone Marrow Aspirate Concentrate and Platelet-Rich Plasma.

Sugaya H, Yoshioka T, Kato T, Taniguchi Y, Kumagai H, Hyodo K, Ohneda O, Yamazaki M, Mishima H.

Bone Marrow Res. 2018 Feb 25;2018:1549826. doi: 10.1155/2018/1549826. eCollection 2018.

42.

A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study.

Matsuda C, Honda M, Tanaka C, Kondo K, Takahashi T, Kosugi C, Tokunaga Y, Takemoto H, Kim HM, Sakamoto J, Oba K, Mishima H.

Cancer Chemother Pharmacol. 2018 Jun;81(6):1035-1041. doi: 10.1007/s00280-018-3568-x. Epub 2018 Apr 11.

PMID:
29644459
43.

A Case of Neurotrophic Keratopathy Associated with Nasopharyngeal Carcinoma.

Sato T, Sugioka K, Kodama-Takahashi A, Fukuda M, Mishima H, Shimomura Y.

Case Rep Ophthalmol. 2018 Feb 16;9(1):114-118. doi: 10.1159/000485965. eCollection 2018 Jan-Apr.

44.

Subacute Urinary Retention due to a Subpubic Cartilaginous Cyst Treated with Surgical Resection and Internal Fixation: A Case Report and Review of the Literature.

Taniguchi Y, Kamada H, Sugaya H, Nishino T, Mishima H, Ochiai N, Yamazaki M.

Case Rep Orthop. 2018 Jan 14;2018:5736341. doi: 10.1155/2018/5736341. eCollection 2018.

45.

╬▒-Melanocyte-stimulating hormone promotes bone resorption resulting from increased osteoblastic and osteoclastic activities in goldfish.

Ishizu H, Sekiguchi T, Ikari T, Kitamura KI, Kitani Y, Endo M, Urata M, Kinoshita Y, Hattori A, Srivastav AK, Mishima H, Mizusawa K, Takahashi A, Suzuki N.

Gen Comp Endocrinol. 2018 Jun 1;262:99-105. doi: 10.1016/j.ygcen.2018.03.020. Epub 2018 Mar 22.

PMID:
29574148
46.

A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trial.

Munemoto Y, Kanda M, Oba K, Kim HM, Takemoto H, Denda T, Nagata N, Takano N, Fukunaga M, Kataoka M, Tokunaga Y, Sakamoto J, Mishima H.

Cancer Chemother Pharmacol. 2018 May;81(5):829-838. doi: 10.1007/s00280-018-3556-1. Epub 2018 Mar 5.

PMID:
29508026
47.

BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer.

Morikawa T, Inada R, Nagasaka T, Mori Y, Kishimoto H, Kawai T, Umeda Y, Mishima H, Goel A, Fujiwara T.

Oncol Lett. 2018 Feb;15(2):2195-2201. doi: 10.3892/ol.2017.7553. Epub 2017 Dec 8.

48.

Corrigendum to "SDF-1 improves wound healing ability of glucocorticoid-treated adipose tissue-derived mesenchymal stem cells" [Biochem. Biophys. Res. Commun. 493/2 (2017) 1010-1017].

Kato T, Khanh VC, Sato K, Takeuchi K, Carolina E, Yamashita T, Sugaya H, Yoshioka T, Mishima H, Ohneda O.

Biochem Biophys Res Commun. 2018 Feb 26;497(1):464-465. doi: 10.1016/j.bbrc.2018.01.179. Epub 2018 Feb 9. No abstract available.

PMID:
29429756
49.

Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.

Sato S, Itonaga H, Taguchi M, Sawayama Y, Imanishi D, Tsushima H, Hata T, Moriuchi Y, Mishima H, Kinoshita A, Yoshiura KI, Miyazaki Y.

Int J Hematol. 2018 Aug;108(2):213-217. doi: 10.1007/s12185-018-2419-1. Epub 2018 Feb 7.

PMID:
29417354
50.

Whole-exome sequencing and gene-based rare variant association tests suggest that PLA2G4E might be a risk gene for panic disorder.

Morimoto Y, Shimada-Sugimoto M, Otowa T, Yoshida S, Kinoshita A, Mishima H, Yamaguchi N, Mori T, Imamura A, Ozawa H, Kurotaki N, Ziegler C, Domschke K, Deckert J, Umekage T, Tochigi M, Kaiya H, Okazaki Y, Tokunaga K, Sasaki T, Yoshiura KI, Ono S.

Transl Psychiatry. 2018 Feb 2;8(1):41. doi: 10.1038/s41398-017-0088-0.

Supplemental Content

Loading ...
Support Center